netFormulary NHS
Birmingham, Sandwell, Solihull and environs APC Formulary
Maintained by Midlands and Lancashire Commissioning Support Unit
 Search
 Formulary Chapter 3: Respiratory system - Full Chapter
Notes:

Prescribing inhalers

• Prescribe by brand or branded-generic name to ensure patients receive the device they are used to.
• Check licensed indication (differences among brands).
• Be aware of differences in excipients among the different brands.
Chapter Links...
Link   COPD Guidelines 2017- Pan Birmingham Respiratory Clinical Network
Link   Equality Analysis - Diagnosis and management of stable COPD- Pan Birmingham Respiratory Clinical Network guideline 2017
Link   Appendix 4 Criteria for triple therapy and for triple inhaler use in COPD
Link   NICE TA10: Asthma inhaler devices (children under 5)
Link   UKMI Q&A: Nebuliser compatibilities
Link   Diagnosis and Management of Asthma in Adults Guideline - Pan Birmingham Respiratory Clinical Network (June 2019)
Link   NICE CG101: COPD guideline
Link   NICE TA38: Asthma inhaler devices (older children)
Link   Stoma Toolkit Adults
 Details...
03.03.01  Expand sub section  Cromoglicate and related therapy
03.03.01  Expand sub section  Related therapy
 ....
 Non Formulary Items
Nedocromil  (Tilade® CFC-free inhaler)

View adult BNF View SPC online View childrens BNF 		Non Formulary
 
Sodium Cromoglicate

View adult BNF View SPC online View childrens BNF 		Non Formulary
 
Sodium Cromoglicate  (Comogen Easi-Breathe®)

View adult BNF View SPC online View childrens BNF 		Non Formulary
 
Sodium Cromoglicate  (Intal®)

View adult BNF View SPC online View childrens BNF 		Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
 Display tracking information
click to search medicines.org.uk
 Link to adult BNF
click to search medicines.org.uk
 Link to children's BNF
click to search medicines.org.uk
 Link to SPCs
Cytotoxic Drug
 Cytotoxic Drug
CD
 Controlled Drug
High Cost Medicine
 High Cost Medicine
Cancer Drugs Fund
 Cancer Drugs Fund
NHSE
 NHS England
Homecare
 Homecare
CCG
 CCG

Traffic Light Status Information

Status Description

Prescribing in children

The APC notes that the informed use of unlicensed medicines or of licensed medicines for unlicensed applications (‘off-label’ use) is often necessary in paediatric practice.

The APC advises GPs to consider specialist prescribing recommendations for Green and Amber medicines that are not subject to ESCAs or RICaDs in combination with the information provided in the BNFC which goes beyond that of marketing authorisations. The BNFC has been designed for rapid reference and the information presented has been carefully selected to aid decisions on prescribing.

  

Green

 Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications.  

Amber

 Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate, or initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.

Some amber medicines require agreement with the local (internal) medicines committee prior to initiation; others may require a framework to support safe transfer and maintenance of care such as a RICaD or ESCA. The Formulary will be annotated to reflect these requirements.   

Red

 Medicines for initiation and maintenance prescribing by Specialists only  

Black

 Non-formulary medicines- medicines not recommended for routine primary care prescribing.  

Grey

 Positive NICE TA and /or awaiting local clarification on place in therapy ; Please contact your Medicines Optimisation team for more information.  

netFormulary